Annual report

Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 107
MetricValuePeriodScopeSource row
Revenue¥14.8bn2025-04-01 → 2026-03-31Cons.Net sales
Operating income¥1.2bn2025-04-01 → 2026-03-31Cons.Operating income
Ordinary income¥1.2bn2025-04-01 → 2026-03-31Cons.Ordinary income
Profit before tax¥1.2bn2025-04-01 → 2026-03-31Cons.Income before income taxes
Net income (owners)¥822m2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent
Net income¥822m2025-04-01 → 2026-03-31Cons.Profit loss
Total assets¥9.7bnat 2026-03-31Cons.Assets
Total liabilities¥3.9bnat 2026-03-31Cons.Liabilities
Net assets / equity¥5.8bnat 2026-03-31Cons.Net assets
Net assets / equity¥3.5bnat 2025-03-31Cons.Net assets
Cash and deposits¥5.3bnat 2026-03-31Cons.Cash and deposits
Cash & equivalents¥5.3bnat 2026-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2025-03-31Cons.Cash and cash equivalents
Operating cash flow¥1.1bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥112m2025-04-01 → 2026-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.5bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥68.132025-04-01 → 2026-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥67.412025-04-01 → 2026-03-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥467.52at 2026-03-31Cons.Net assets per share (5-year summary)
Equity ratio59.9%at 2026-03-31Cons.Equity to asset ratio (5-year summary)
ROE14.1%2025-04-01 → 2026-03-31Cons.Rate of return on equity (5-year summary)
Employees263at 2026-03-31Cons.Number of employees
Revenue¥14.6bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥14.1bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥13.3bn2023-04-01 → 2024-03-31dStandaloneNet sales (5-year summary)
Revenue¥10.7bn2022-04-01 → 2023-03-31dStandaloneNet sales (5-year summary)
Revenue¥9.3bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Operating income¥1.2bn2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥1.1bn2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥1.2bn2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥1.1bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥955m2023-04-01 → 2024-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥812m2022-04-01 → 2023-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥657m2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥1.2bn2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥1.1bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥805m2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥776m2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥680m2023-04-01 → 2024-03-31dStandaloneNet income loss (5-year summary)
Net income¥560m2022-04-01 → 2023-03-31dStandaloneNet income loss (5-year summary)
Net income¥443m2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Total assets¥7.6bnat 2026-03-31StandaloneAssets
Total assets¥5.2bnat 2025-03-31StandaloneAssets
Total assets¥4.6bnat 2024-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2023-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.2bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.8bnat 2026-03-31StandaloneLiabilities
Total liabilities¥1.7bnat 2025-03-31StandaloneLiabilities
Net assets / equity¥5.8bnat 2026-03-31StandaloneNet assets
Net assets / equity¥3.5bnat 2025-03-31StandaloneNet assets
Net assets / equity¥2.9bnat 2024-03-31dStandaloneNet assets
Net assets / equity¥2.4bnat 2023-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.9bnat 2022-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥5.0bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥2.8bnat 2025-03-31StandaloneCash and deposits
Cash & equivalents¥2.8bnat 2025-03-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.6bnat 2024-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.6bnat 2023-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.2bnat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥1.7bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥555m2023-04-01 → 2024-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥953m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥408m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥269m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥426m2023-04-01 → 2024-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥405m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥155m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥213m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥179m2023-04-01 → 2024-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥148m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥119m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥66.72025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥71.232024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥62.442023-04-01 → 2024-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥51.412022-04-01 → 2023-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥40.652021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥65.992025-04-01 → 2026-03-31StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥34.42025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥42.752024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥37.472023-04-01 → 2024-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥30.862022-04-01 → 2023-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥24.42021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥466.14at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥316.77at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥264.27at 2024-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥217.25at 2023-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥178.04at 2022-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio76.3%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.6%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio62.2%at 2024-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio60.5%at 2023-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio60.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE17.4%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE24.5%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE25.9%2023-04-01 → 2024-03-31dStandaloneRate of return on equity (5-year summary)
ROE26.0%2022-04-01 → 2023-03-31dStandaloneRate of return on equity (5-year summary)
ROE25.0%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued12,463,400at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,448,200at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,448,200at 2024-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued5,448,200at 2023-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued5,448,200at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees128at 2026-03-31StandaloneNumber of employees
Employees122at 2025-03-31StandaloneNumber of employees
Employees108at 2024-03-31dStandaloneNumber of employees
Employees103at 2023-03-31dStandaloneNumber of employees
Employees90at 2022-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 17
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2025-04-01 → 2026-03-31¥40m
Health Management Cloud Businessreportable segmentdepreciation2025-04-01 → 2026-03-31¥101m
Health Management Cloud Businessreportable segmentemployeesat 2026-03-31157 pure
Health Management Cloud Businessreportable segmentrevenue2025-04-01 → 2026-03-31¥1.5bn
Health Management Cloud Businessreportable segmentrevenue external2025-04-01 → 2026-03-31¥1.5bn
Health Management Cloud Businessreportable segmentsegment profit2025-04-01 → 2026-03-31¥767m
Medical Checkup Solution Businessreportable segmentdepreciation2025-04-01 → 2026-03-31¥130m
Medical Checkup Solution Businessreportable segmentemployeesat 2026-03-3154 pure
Medical Checkup Solution Businessreportable segmentrevenue2025-04-01 → 2026-03-31¥13.0bn
Medical Checkup Solution Businessreportable segmentrevenue external2025-04-01 → 2026-03-31¥13.0bn
Medical Checkup Solution Businessreportable segmentsegment profit2025-04-01 → 2026-03-31¥379m
Medical Institution Support Businessreportable segmentdepreciation2025-04-01 → 2026-03-31¥11m
Medical Institution Support Businessreportable segmentrevenue2025-04-01 → 2026-03-31¥236m
Medical Institution Support Businessreportable segmentrevenue external2025-04-01 → 2026-03-31¥236m
Medical Institution Support Businessreportable segmentsegment profit2025-04-01 → 2026-03-31¥40m
Health Management Cloud Businessreportable segmentemployeesat 2026-03-3122 pure
Medical Checkup Solution Businessreportable segmentemployeesat 2026-03-3154 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,037
ItemContextValueUnit
Audits (text)FilingDateInstantText · Plus
Remuneration for directors and other officers (text)FilingDateInstantText · Plus
Remuneration etc paid by group to each director or other officer (text)FilingDateInstantText · Plus
Shareholdings (text)FilingDateInstantText · Plus
Basic policy on human resources strategy employees etc (text)FilingDateInstantText · Plus
Information about employees (text)FilingDateInstantText · Plus
Consolidated subsidiaries metrics of consolidated subsidiariesCurrentYearInstant_Row1Member
Original text (Japanese)株式会社あしたのチーム
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYearDurationText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYearDurationText · Plus
Description of fact that financial statements have been prepared in accordance with special provision financial informationCurrentYearDuration
Original text (Japanese)当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。
Notes no description of the comparative information financial information (text)CurrentYearDurationText · Plus
Note on independent audit financial informationCurrentYearDurationText · Plus
Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial informationCurrentYearDurationText · Plus
Consolidated balance sheet (text)CurrentYearDurationText · Plus
Consolidated statement of income (text)CurrentYearDurationText · Plus
Consolidated statement of comprehensive income (text)CurrentYearDurationText · Plus
Consolidated statement of changes in equity (text)CurrentYearDurationText · Plus
Consolidated statement of cash flows (text)CurrentYearDurationText · Plus
Notes uncertainties of entitys ability to continue as going concern consolidated financial statements (text)CurrentYearDurationText · Plus
Notes significant accounting policies for preparation of consolidated financial statements (text)CurrentYearDurationText · Plus
Number of consolidated subsidiaries and names of major consolidated subsidiaries (text)CurrentYearDurationText · Plus
Changes in scope of consolidation (text)CurrentYearDurationText · Plus
Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text)CurrentYearDurationText · Plus
Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text)CurrentYearDurationText · Plus
Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text)CurrentYearDurationText · Plus
Disclosure about fiscal years etc of consolidated subsidiaries (text)CurrentYearDurationText · Plus
Disclosure of accounting policies (text)CurrentYearDurationText · Plus
Significant accounting estimates consolidated financial statements (text)CurrentYearDurationText · Plus
Notes new accounting standards not yet applied consolidated financial statements (text)CurrentYearDurationText · Plus
Notes changes in accounting estimates consolidated financial statements (text)CurrentYearDurationText · Plus
Notes regarding amounts of notes and accounts receivable trade and contract assets (text)CurrentYearInstantText · Plus
Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text)CurrentYearInstantText · Plus
Notes regarding accumulated depreciation of property plant and equipment (text)CurrentYearInstantText · Plus
Debtors notes regarding overdraft contracts and or loan commitments (text)CurrentYearInstantText · Plus
Notes regarding amount of revenue from contracts with customers (text)CurrentYearDurationText · Plus
Major components of selling general and administrative expenses (text)CurrentYearDurationText · Plus
Notes regarding issued shares and treasury shares (text)CurrentYearDurationText · Plus
Notes regarding new share subscription rights etc (text)CurrentYearDurationText · Plus
Notes regarding dividend (text)CurrentYearDurationText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYearDurationText · Plus
Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text)CurrentYearDurationText · Plus
Notes leases consolidated financial statements (text)CurrentYearDurationText · Plus
Notes financial instruments consolidated financial statements (text)CurrentYearDurationText · Plus
Notes retirement benefits consolidated financial statements (text)CurrentYearDurationText · Plus
Notes share options etc consolidated financial statements (text)CurrentYearDurationText · Plus
Notes tax effect accounting consolidated financial statements (text)CurrentYearDurationText · Plus
Notes business combinations consolidated financial statements (text)CurrentYearDurationText · Plus
Notes asset retirement obligations consolidated financial statements (text)CurrentYearDurationText · Plus
Notes revenue recognition consolidated financial statements (text)CurrentYearDurationText · Plus
Notes segment information etc consolidated financial statements (text)CurrentYearDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2026-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass
balance sheet identitynon_consolidated 2026-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2026-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass